TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -2 | -4 | -7 | -6 | -22 | -14 | -9 |
| P | %wins | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| S | %ret | 1 | 1 | 1 | -1 | 0 | 1 | 9 | 5 | 27 | 8 |
| S | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/10/16 18:55 | 3/9/16 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Coffman Vance D | CA | D | M.d | 252 | 50.44 | 33 | 5 | 14 | 42 | D | 17 | -6 | -8 | -10 | -6 | -6 | -1 | -3 | 3 | 2 | 11 | 13 | 23 | 30 | |
2/6/15 18:23 | 2/6/15 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Coffman Vance D | CA | D | M.d | 211 | 42.13 | 33 | 5 | 16 | 37 | D | 84 | 36 | 22 | -4 | -3 | 1 | -3 | 1 | -1 | 2 | 3 | 5 | 13 | -2 | |
9/9/14 18:54 | 9/5/14 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Coffman Vance D | CA | D | M.d | 1,136 | 56.79 | 33 | 20 | 149 | 33 | D | 72 | 28 | 12 | 20 | 14 | 5 | 1 | 0 | 1 | 0 | -1 | 23 | 13 | 14 | |
11/5/08 12:41 | 11/4/08 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Coffman Vance D | CA | D | P | 500 | 60.50 | 33 | 8 | 344 | 11 | D | -20 | 5 | 44 | -5 | 4 | 27 | 6 | 0 | -2 | -4 | -7 | -6 | -22 | -14 | |
2/25/05 16:18 | 2/23/05 | LMT | Lockheed Martin Corp | MD | Aero | Aero | Guided Missiles & Space Vehic | Coffman Vance D | MD | D | M.dm | 20,958 | 40.30 | 33 | 520 | 0 | D | 34 | 28 | 10 | 1 | 6 | 2 | 0 | 0 | -1 | 0 | 1 | 9 | 5 | 27 | ||
2/25/05 16:18 | 2/23/05 | LMT | Lockheed Martin Corp | MD | Aero | Aero | Guided Missiles & Space Vehic | Coffman Vance D | MD | D | S.dm | 0 | 0.00 | 33 | -520 | -100 | 0 | D | 34 | 28 | 10 | 1 | 6 | 2 | 0 | 0 | -1 | 0 | 1 | 9 | 5 | 27 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |